JP2023145686A5 - - Google Patents

Download PDF

Info

Publication number
JP2023145686A5
JP2023145686A5 JP2023126654A JP2023126654A JP2023145686A5 JP 2023145686 A5 JP2023145686 A5 JP 2023145686A5 JP 2023126654 A JP2023126654 A JP 2023126654A JP 2023126654 A JP2023126654 A JP 2023126654A JP 2023145686 A5 JP2023145686 A5 JP 2023145686A5
Authority
JP
Japan
Prior art keywords
exo
isx
cpcs
cpc
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023126654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023145686A (ja
JP7837302B2 (ja
Filing date
Publication date
Priority claimed from US15/881,693 external-priority patent/US20180273906A1/en
Application filed filed Critical
Publication of JP2023145686A publication Critical patent/JP2023145686A/ja
Publication of JP2023145686A5 publication Critical patent/JP2023145686A5/ja
Application granted granted Critical
Publication of JP7837302B2 publication Critical patent/JP7837302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023126654A 2018-01-26 2023-08-03 治療用途のための微小胞および幹細胞組成物 Active JP7837302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/881,693 US20180273906A1 (en) 2014-04-17 2018-01-26 Microvesicle and stem cell compositions for therapeutic applications
US15/881,693 2018-01-26
JP2019011767A JP2019201631A (ja) 2018-01-26 2019-01-28 治療用微小胞と幹細胞の合成

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019011767A Division JP2019201631A (ja) 2018-01-26 2019-01-28 治療用微小胞と幹細胞の合成

Publications (3)

Publication Number Publication Date
JP2023145686A JP2023145686A (ja) 2023-10-11
JP2023145686A5 true JP2023145686A5 (https=) 2025-02-04
JP7837302B2 JP7837302B2 (ja) 2026-03-30

Family

ID=68725220

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019011767A Pending JP2019201631A (ja) 2018-01-26 2019-01-28 治療用微小胞と幹細胞の合成
JP2023126654A Active JP7837302B2 (ja) 2018-01-26 2023-08-03 治療用途のための微小胞および幹細胞組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019011767A Pending JP2019201631A (ja) 2018-01-26 2019-01-28 治療用微小胞と幹細胞の合成

Country Status (2)

Country Link
US (2) US20180273906A1 (https=)
JP (2) JP2019201631A (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
US20180273906A1 (en) * 2014-04-17 2018-09-27 Muhammad Ashraf Microvesicle and stem cell compositions for therapeutic applications
CA3202332A1 (en) 2015-12-07 2017-06-15 Agex Therapeutics, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
KR20180057546A (ko) * 2016-11-21 2018-05-30 성균관대학교산학협력단 지방줄기세포유래 엑소좀을 유효성분으로 포함하는 간 섬유증 예방 또는 치료용 조성물
CN112334190B (zh) * 2018-04-30 2024-09-20 儿童医学中心公司 间充质基质细胞外排体及其用途
CN109266603A (zh) * 2018-08-29 2019-01-25 浙江大学 一种提高心梗疗效的外泌体及应用
US12508325B2 (en) 2018-12-20 2025-12-30 Ohio State Innovation Foundation Compositions and methods for reprogramming diseased musculoskeletal cells
WO2020132161A1 (en) * 2018-12-21 2020-06-25 The Regents Of The University Of California Compositions and methods for treating hearing loss
CN114207110A (zh) * 2019-03-28 2022-03-18 Agex治疗公司 使用细胞外囊泡诱导的组织再生
KR20220039647A (ko) * 2019-04-03 2022-03-29 더 존스 홉킨스 유니버시티 골격근 줄기세포 생성 및 질환 치료를 위한 방법, 조성물 및 키트
US20220233604A1 (en) * 2019-05-15 2022-07-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating cardiomyocytes
CN110257333A (zh) * 2019-05-27 2019-09-20 江苏大学 一种神经干细胞微囊泡及其应用
CN110724665A (zh) * 2019-11-21 2020-01-24 西安外事学院 一种iPS细胞培养上清液及其制备方法和应用
WO2021114164A1 (zh) * 2019-12-12 2021-06-17 中国科学院深圳先进技术研究院 一种外泌体及其制备方法及应用
CN115175986B (zh) 2020-02-10 2024-11-08 公立大学法人名古屋市立大学 用于诱导多能干细胞向脑毛细血管内皮样细胞分化的涂布剂及其利用
CN111961645A (zh) * 2020-09-01 2020-11-20 杭州优渡生物科技有限公司 一种高效扩增人表皮成纤维细胞的培养基
CN116806257A (zh) * 2020-10-14 2023-09-26 达芬奇环球有限公司 心肌干细胞/心肌前体细胞的制备方法及心肌纤维化抑制方法
EP4247938A4 (en) * 2020-11-18 2024-05-15 FUJIFILM Corporation Generation of secretome-containing compositions, and methods of using and analyzing the same
CN112608972B (zh) * 2020-12-21 2021-09-10 广东源心再生医学有限公司 Myog基因作为靶点在制备治疗心肌细胞凋亡相关的心血管疾病的药物中的应用
CN114645021A (zh) * 2020-12-21 2022-06-21 未来智人再生医学研究院(广州)有限公司 一种表达靶向cd47抑制因子的多能干细胞及其衍生物与应用
CN114657130A (zh) * 2020-12-22 2022-06-24 未来智人再生医学研究院(广州)有限公司 一种表达vegf-a靶向抑制因子的多能干细胞及其衍生物与应用
CN113209135B (zh) * 2021-04-23 2023-06-13 奥启(深圳)生物科技有限公司 一种用于延缓皮肤衰老的间充质干细胞外泌体制剂
CN113322226A (zh) * 2021-06-28 2021-08-31 华南理工大学 三维培养胚胎干细胞来源的外泌体及在制备治疗肝纤维化药物的应用
JPWO2023079655A1 (https=) * 2021-11-04 2023-05-11
WO2023136313A1 (ja) * 2022-01-14 2023-07-20 国立大学法人大阪大学 肝機能障害を処置するための組成物
WO2023154466A1 (en) * 2022-02-11 2023-08-17 The University Of North Carolina At Chapel Hill Arylbenzoisoxazole compounds as ip6k and ipmk inhibitors and methods of use thereof
KR102816689B1 (ko) * 2022-03-29 2025-06-02 박동선 Tsg101 단백질을 암호화하는 폴리뉴클레오티드가 도입된 줄기세포 및 이의 용도
PL443827A1 (pl) * 2023-02-18 2024-08-19 Uniwersytet Jagielloński Sposób otrzymywania pęcherzyków zewnątrzkomórkowych (EVs) pochodzących z indukowanych pluripotencjalnych komórek macierzystych (iPSC) oraz ich zastosowanie
WO2025117472A1 (en) * 2023-11-30 2025-06-05 Immorta Bio, Inc. Treatment of heart failure using pluripotent stem cell derived cardiomyocytes and derivatives thereof
WO2025160404A1 (en) * 2024-01-26 2025-07-31 FUJIFILM Cellular Dynamics, Inc. Generation of secretome-containing compositions, and methods of using and analyzing the same
WO2025247999A1 (en) * 2024-05-30 2025-12-04 Conveyxo Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles
EP4656187A1 (en) * 2024-05-30 2025-12-03 ConvEyXo Method for the production of extracellular vesicles loaded with a molecule of interest and composition comprising such extracellular vesicles
CN120131648B (zh) * 2025-03-06 2025-11-25 上海市重大传染病和生物安全研究院 一种hiv-1潜伏感染激活剂、药物及用途
CN120437124A (zh) * 2025-06-10 2025-08-08 南方医科大学 小分子isx-9在促进间充质干细胞成骨分化和骨损伤再生修复中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10443044B2 (en) 2014-04-17 2019-10-15 Ips Heart Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compounds
US20150297638A1 (en) * 2014-04-17 2015-10-22 Muhammad Ashraf Chemically induced pluripotent stem cells for safe therapeutic applications
US20180273906A1 (en) 2014-04-17 2018-09-27 Muhammad Ashraf Microvesicle and stem cell compositions for therapeutic applications
WO2016108288A1 (ja) 2014-12-29 2016-07-07 国立大学法人京都大学 骨格筋前駆細胞の製造方法
WO2017196175A1 (en) 2016-05-12 2017-11-16 Erasmus University Medical Center Rotterdam A method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium.

Similar Documents

Publication Publication Date Title
JP2023145686A5 (https=)
Goradel et al. Stem cell therapy: a new therapeutic option for cardiovascular diseases
Bollini et al. Resident cardiac progenitor cells: at the heart of regeneration
Burdon et al. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential
Hida et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells
Moon et al. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction
CN103340902B (zh) 含有心源性因子的组合物和相关方法、细胞,以及所述组合物、方法和细胞的应用
US8771677B2 (en) Colony-forming unit cell of human chorion and method to obtain and use thereof
US20220387518A1 (en) Immortalized cardiac stem cells for cardiac repair
JP2009531021A (ja) 骨格筋周囲血管芽細胞および心筋中胚葉性血管芽細胞、それらの単離および使用方法
US20130330825A1 (en) Attachment substrates for directed differentiation of human embryonic stem cells in culture
WO2022135279A1 (zh) Myog基因作为靶点在制备治疗心肌细胞凋亡相关的心血管疾病的药物中的应用
Devarajan et al. Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype
Pagano et al. Normal versus pathological cardiac fibroblast‐derived extracellular matrix differentially modulates cardiosphere‐derived cell paracrine properties and commitment
Sharma et al. Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretome
Morrissette-McAlmon et al. Adipocyte-mediated electrophysiological remodeling of human stem cell-derived cardiomyocytes
US9969978B2 (en) Method for producing cardiomyocytes from human or mouse embryonic stem cells in a medium consisting of a serum-free medium and N2 supplement
CN115369077B (zh) Meflc细胞株及其构建方法和应用
US8513011B2 (en) Methods and compositions for culturing cardiomyocyte-like cells
CN102888401B (zh) 一种诱导多功能干细胞的抑制剂、其诱导方法和用途
Lou Tissue Engineered Cardiac Muscle Patches with Human Pluripotent Stem Cells Enhance the Repairing Efficacy of Infarcted Cardiac Muscle in Mouse Model
Lou Human Pluripotent Stem Cells and Patches Enhance the Repairing Efficacy of Infarcted Cardiac Muscle in Mouse Model
Poudel et al. Increased cardiogenesis in P19-GFP teratocarcinoma cells expressing the propeptide IGF-1Ea
JP2024538839A (ja) 転帰不良のリスクが高い対象における進行性心不全の治療方法
HK40094422A (en) Immortalized cardiac stem cells for cardiac repair